This review summarizes pathological muscle differentiation focusing on the role played by DUX4 in FSHD muscle in order to better understand the pathophysiology of the disease and to provide novel possible therapeutic strategies targeting DUX4 aberrant expression. The gene discussed is DUX4; the disease is Facioscapulohumeral dystrophy.